Skip to main content
Premium Trial:

Request an Annual Quote

Cellomics to Provide HCS Equipment for China s National Center for Drug Screening

NEW YORK, Sep 2 (GenomeWeb News) - Cellomics said today that it is collaborating with the National Center for Drug Screening in Shanghai, China, in the area of high content screening.

 

Cellomics will serve as a "strategic partner" in the establishment of an HCS program at the center, according to a statement by Ming-Wei Wang, director of the NCDS. Further terms of the agreement were not provided.

 

The NationalCenter for Drug Screening is affiliated with the Shanghai Institute of Materia Medica at the ChineseAcademy of Sciences.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.